Global Infantile Spasms Therapeutics Market Research Report 2022
SKU ID : QYR-21014363 | Publishing Date : 06-Jun-2022 | No. of pages : 88
Detailed TOC of Global Infantile Spasms Therapeutics Market Research Report 2022
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infantile Spasms Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Oral
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Infantile Spasms Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Infantile Spasms Therapeutics Market Perspective (2017-2028)
2.2 Infantile Spasms Therapeutics Growth Trends by Region
2.2.1 Infantile Spasms Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Infantile Spasms Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Infantile Spasms Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Infantile Spasms Therapeutics Market Dynamics
2.3.1 Infantile Spasms Therapeutics Industry Trends
2.3.2 Infantile Spasms Therapeutics Market Drivers
2.3.3 Infantile Spasms Therapeutics Market Challenges
2.3.4 Infantile Spasms Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infantile Spasms Therapeutics Players by Revenue
3.1.1 Global Top Infantile Spasms Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Infantile Spasms Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Infantile Spasms Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Infantile Spasms Therapeutics Revenue
3.4 Global Infantile Spasms Therapeutics Market Concentration Ratio
3.4.1 Global Infantile Spasms Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infantile Spasms Therapeutics Revenue in 2021
3.5 Infantile Spasms Therapeutics Key Players Head office and Area Served
3.6 Key Players Infantile Spasms Therapeutics Product Solution and Service
3.7 Date of Enter into Infantile Spasms Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Infantile Spasms Therapeutics Breakdown Data by Type
4.1 Global Infantile Spasms Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Infantile Spasms Therapeutics Forecasted Market Size by Type (2023-2028)
5 Infantile Spasms Therapeutics Breakdown Data by Application
5.1 Global Infantile Spasms Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Infantile Spasms Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Infantile Spasms Therapeutics Market Size (2017-2028)
6.2 North America Infantile Spasms Therapeutics Market Size by Country (2017-2022)
6.3 North America Infantile Spasms Therapeutics Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Infantile Spasms Therapeutics Market Size (2017-2028)
7.2 Europe Infantile Spasms Therapeutics Market Size by Country (2017-2022)
7.3 Europe Infantile Spasms Therapeutics Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Infantile Spasms Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Infantile Spasms Therapeutics Market Size by Country (2017-2022)
8.3 Asia-Pacific Infantile Spasms Therapeutics Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Infantile Spasms Therapeutics Market Size (2017-2028)
9.2 Latin America Infantile Spasms Therapeutics Market Size by Country (2017-2022)
9.3 Latin America Infantile Spasms Therapeutics Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infantile Spasms Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Infantile Spasms Therapeutics Market Size by Country (2017-2022)
10.3 Middle East & Africa Infantile Spasms Therapeutics Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Mallinckrodt
11.1.1 Mallinckrodt Company Detail
11.1.2 Mallinckrodt Business Overview
11.1.3 Mallinckrodt Infantile Spasms Therapeutics Introduction
11.1.4 Mallinckrodt Revenue in Infantile Spasms Therapeutics Business (2017-2022)
11.1.5 Mallinckrodt Recent Development
11.2 H. Lundbeck
11.2.1 H. Lundbeck Company Detail
11.2.2 H. Lundbeck Business Overview
11.2.3 H. Lundbeck Infantile Spasms Therapeutics Introduction
11.2.4 H. Lundbeck Revenue in Infantile Spasms Therapeutics Business (2017-2022)
11.2.5 H. Lundbeck Recent Development
11.3 Insys Therapeutics
11.3.1 Insys Therapeutics Company Detail
11.3.2 Insys Therapeutics Business Overview
11.3.3 Insys Therapeutics Infantile Spasms Therapeutics Introduction
11.3.4 Insys Therapeutics Revenue in Infantile Spasms Therapeutics Business (2017-2022)
11.3.5 Insys Therapeutics Recent Development
11.4 Orphelia Pharma
11.4.1 Orphelia Pharma Company Detail
11.4.2 Orphelia Pharma Business Overview
11.4.3 Orphelia Pharma Infantile Spasms Therapeutics Introduction
11.4.4 Orphelia Pharma Revenue in Infantile Spasms Therapeutics Business (2017-2022)
11.4.5 Orphelia Pharma Recent Development
11.5 Valerion Therapeutics
11.5.1 Valerion Therapeutics Company Detail
11.5.2 Valerion Therapeutics Business Overview
11.5.3 Valerion Therapeutics Infantile Spasms Therapeutics Introduction
11.5.4 Valerion Therapeutics Revenue in Infantile Spasms Therapeutics Business (2017-2022)
11.5.5 Valerion Therapeutics Recent Development
11.6 Catalyst Pharmaceuticals
11.6.1 Catalyst Pharmaceuticals Company Detail
11.6.2 Catalyst Pharmaceuticals Business Overview
11.6.3 Catalyst Pharmaceuticals Infantile Spasms Therapeutics Introduction
11.6.4 Catalyst Pharmaceuticals Revenue in Infantile Spasms Therapeutics Business (2017-2022)
11.6.5 Catalyst Pharmaceuticals Recent Development
11.7 Anavex Life Sciences
11.7.1 Anavex Life Sciences Company Detail
11.7.2 Anavex Life Sciences Business Overview
11.7.3 Anavex Life Sciences Infantile Spasms Therapeutics Introduction
11.7.4 Anavex Life Sciences Revenue in Infantile Spasms Therapeutics Business (2017-2022)
11.7.5 Anavex Life Sciences Recent Development
11.8 Retrophin
11.8.1 Retrophin Company Detail
11.8.2 Retrophin Business Overview
11.8.3 Retrophin Infantile Spasms Therapeutics Introduction
11.8.4 Retrophin Revenue in Infantile Spasms Therapeutics Business (2017-2022)
11.8.5 Retrophin Recent Development
11.9 GW Pharmaceuticals
11.9.1 GW Pharmaceuticals Company Detail
11.9.2 GW Pharmaceuticals Business Overview
11.9.3 GW Pharmaceuticals Infantile Spasms Therapeutics Introduction
11.9.4 GW Pharmaceuticals Revenue in Infantile Spasms Therapeutics Business (2017-2022)
11.9.5 GW Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Infantile Spasms Therapeutics Market Research Report 2022
List of TablesTable 1. Global Infantile Spasms Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Oral
Table 3. Key Players of Injection
Table 4. Global Infantile Spasms Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Infantile Spasms Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Infantile Spasms Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Infantile Spasms Therapeutics Market Share by Region (2017-2022)
Table 8. Global Infantile Spasms Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Infantile Spasms Therapeutics Market Share by Region (2023-2028)
Table 10. Infantile Spasms Therapeutics Market Trends
Table 11. Infantile Spasms Therapeutics Market Drivers
Table 12. Infantile Spasms Therapeutics Market Challenges
Table 13. Infantile Spasms Therapeutics Market Restraints
Table 14. Global Infantile Spasms Therapeutics Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Infantile Spasms Therapeutics Market Share by Players (2017-2022)
Table 16. Global Top Infantile Spasms Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infantile Spasms Therapeutics as of 2021)
Table 17. Ranking of Global Top Infantile Spasms Therapeutics Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Infantile Spasms Therapeutics Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Infantile Spasms Therapeutics Product Solution and Service
Table 21. Date of Enter into Infantile Spasms Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Infantile Spasms Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Infantile Spasms Therapeutics Revenue Market Share by Type (2017-2022)
Table 25. Global Infantile Spasms Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Infantile Spasms Therapeutics Revenue Market Share by Type (2023-2028)
Table 27. Global Infantile Spasms Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Infantile Spasms Therapeutics Revenue Market Share by Application (2017-2022)
Table 29. Global Infantile Spasms Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Infantile Spasms Therapeutics Revenue Market Share by Application (2023-2028)
Table 31. North America Infantile Spasms Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Infantile Spasms Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Infantile Spasms Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Infantile Spasms Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Infantile Spasms Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Infantile Spasms Therapeutics Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Infantile Spasms Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Infantile Spasms Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Infantile Spasms Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Infantile Spasms Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 41. Mallinckrodt Company Detail
Table 42. Mallinckrodt Business Overview
Table 43. Mallinckrodt Infantile Spasms Therapeutics Product
Table 44. Mallinckrodt Revenue in Infantile Spasms Therapeutics Business (2017-2022) & (US$ Million)
Table 45. Mallinckrodt Recent Development
Table 46. H. Lundbeck Company Detail
Table 47. H. Lundbeck Business Overview
Table 48. H. Lundbeck Infantile Spasms Therapeutics Product
Table 49. H. Lundbeck Revenue in Infantile Spasms Therapeutics Business (2017-2022) & (US$ Million)
Table 50. H. Lundbeck Recent Development
Table 51. Insys Therapeutics Company Detail
Table 52. Insys Therapeutics Business Overview
Table 53. Insys Therapeutics Infantile Spasms Therapeutics Product
Table 54. Insys Therapeutics Revenue in Infantile Spasms Therapeutics Business (2017-2022) & (US$ Million)
Table 55. Insys Therapeutics Recent Development
Table 56. Orphelia Pharma Company Detail
Table 57. Orphelia Pharma Business Overview
Table 58. Orphelia Pharma Infantile Spasms Therapeutics Product
Table 59. Orphelia Pharma Revenue in Infantile Spasms Therapeutics Business (2017-2022) & (US$ Million)
Table 60. Orphelia Pharma Recent Development
Table 61. Valerion Therapeutics Company Detail
Table 62. Valerion Therapeutics Business Overview
Table 63. Valerion Therapeutics Infantile Spasms Therapeutics Product
Table 64. Valerion Therapeutics Revenue in Infantile Spasms Therapeutics Business (2017-2022) & (US$ Million)
Table 65. Valerion Therapeutics Recent Development
Table 66. Catalyst Pharmaceuticals Company Detail
Table 67. Catalyst Pharmaceuticals Business Overview
Table 68. Catalyst Pharmaceuticals Infantile Spasms Therapeutics Product
Table 69. Catalyst Pharmaceuticals Revenue in Infantile Spasms Therapeutics Business (2017-2022) & (US$ Million)
Table 70. Catalyst Pharmaceuticals Recent Development
Table 71. Anavex Life Sciences Company Detail
Table 72. Anavex Life Sciences Business Overview
Table 73. Anavex Life Sciences Infantile Spasms Therapeutics Product
Table 74. Anavex Life Sciences Revenue in Infantile Spasms Therapeutics Business (2017-2022) & (US$ Million)
Table 75. Anavex Life Sciences Recent Development
Table 76. Retrophin Company Detail
Table 77. Retrophin Business Overview
Table 78. Retrophin Infantile Spasms Therapeutics Product
Table 79. Retrophin Revenue in Infantile Spasms Therapeutics Business (2017-2022) & (US$ Million)
Table 80. Retrophin Recent Development
Table 81. GW Pharmaceuticals Company Detail
Table 82. GW Pharmaceuticals Business Overview
Table 83. GW Pharmaceuticals Infantile Spasms Therapeutics Product
Table 84. GW Pharmaceuticals Revenue in Infantile Spasms Therapeutics Business (2017-2022) & (US$ Million)
Table 85. GW Pharmaceuticals Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Infantile Spasms Therapeutics Market Share by Type: 2021 VS 2028
Figure 2. Oral Features
Figure 3. Injection Features
Figure 4. Global Infantile Spasms Therapeutics Market Share by Application in 2021 & 2028
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Other Case Studies
Figure 8. Infantile Spasms Therapeutics Report Years Considered
Figure 9. Global Infantile Spasms Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Infantile Spasms Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Infantile Spasms Therapeutics Market Share by Region: 2021 VS 2028
Figure 12. Global Infantile Spasms Therapeutics Market Share by Players in 2021
Figure 13. Global Top Infantile Spasms Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infantile Spasms Therapeutics as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Infantile Spasms Therapeutics Revenue in 2021
Figure 15. North America Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Infantile Spasms Therapeutics Market Share by Country (2017-2028)
Figure 17. United States Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Infantile Spasms Therapeutics Market Share by Country (2017-2028)
Figure 21. Germany Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Infantile Spasms Therapeutics Market Share by Region (2017-2028)
Figure 29. China Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Infantile Spasms Therapeutics Market Share by Country (2017-2028)
Figure 37. Mexico Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Infantile Spasms Therapeutics Market Share by Country (2017-2028)
Figure 41. Turkey Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Infantile Spasms Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Mallinckrodt Revenue Growth Rate in Infantile Spasms Therapeutics Business (2017-2022)
Figure 44. H. Lundbeck Revenue Growth Rate in Infantile Spasms Therapeutics Business (2017-2022)
Figure 45. Insys Therapeutics Revenue Growth Rate in Infantile Spasms Therapeutics Business (2017-2022)
Figure 46. Orphelia Pharma Revenue Growth Rate in Infantile Spasms Therapeutics Business (2017-2022)
Figure 47. Valerion Therapeutics Revenue Growth Rate in Infantile Spasms Therapeutics Business (2017-2022)
Figure 48. Catalyst Pharmaceuticals Revenue Growth Rate in Infantile Spasms Therapeutics Business (2017-2022)
Figure 49. Anavex Life Sciences Revenue Growth Rate in Infantile Spasms Therapeutics Business (2017-2022)
Figure 50. Retrophin Revenue Growth Rate in Infantile Spasms Therapeutics Business (2017-2022)
Figure 51. GW Pharmaceuticals Revenue Growth Rate in Infantile Spasms Therapeutics Business (2017-2022)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Keyplayers in Global Infantile Spasms Therapeutics Market Research Report 2022
MallinckrodtH. Lundbeck
Insys Therapeutics
Orphelia Pharma
Valerion Therapeutics
Catalyst Pharmaceuticals
Anavex Life Sciences
Retrophin
GW Pharmaceuticals